Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of this study was to clarify whether human amniotic fluid (AF) contains a significant level of bioactive lysophosphatidic acid (LPA) and, whether
autotaxin
(
ATX
) is involved in the production of LPA, if present. Using LC-MS/MS, we found a higher ratio of levels of LPA and its precursor lysophosphatidylcholine (LPC) in AF collected after parturition than that in AF collected at the middle stage of pregnancy. We detected significant choline-producing enzymatic activity toward an exogenous LPC in AF at the middle stage of pregnancy, about half of which was ascribable to
ATX
. In AF collected after parturition, the
ATX
-independent choline-producing activity of glycerophosphcholine
phosphodiesterase
coupled to lysophospholipase A activity was increased in relative to the lysophospholipase D activity of
ATX
. These results suggest that the increased LPA/LPC ratio in AF at the term of pregnancy was due to not only a moderate increase in the level of LPC, but also an unknown mechanism involving epithelial cells bathed with AF.
...
PMID:Distinct contributions of two choline-producing enzymatic activities to lysophosphatidic acid production in human amniotic fluid from pregnant women in the second trimester and after parturition. 3258 50
<< Previous
1
2
3
4
5
6
7
8
9
10